Long-term outcomes of anti-VEGF treatment with 5+PRN regimen for macular edema due to central retinal vein occlusion.

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

http://www.ncbi.nlm.nih.gov/pubmed/37854371

Qiao-Wei Wu; Ya Ye; Yan-Nian Hui; Yan-Ping Song; Yu-Meng Deng; Zhen Huang

Oct 19, 2023